Drug Trial Radar · NCT00811720
Efficacy of Nalmefene in Patients With Alcohol Dependence
Last checked: Nov 20, 2026Latest source record: Jul 9, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
598
Actual
Start
Dec 2008
Primary completion
Oct 2010
Study completion Nov 2010
Sponsor
- Lead sponsor
- H. Lundbeck A/SIndustry
- Sponsor type
- Industry
- First posted
- Dec 19, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the efficacy, safety and tolerability of nalmefene in the treatment of alcohol dependence.
Conditions
- Alcohol Dependence
Interventions
PlaceboDrug
as-needed use, tablets, orally, 6 months
NalmefeneDrug
18.06 mg, as-needed use, tablets, orally, 6 months. 18.06 mg nalmefene equals 20 mg nalmefene hydrochloride.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Monthly Number of Heavy Drinking Days (HDDs)Time frame: Baseline and Month 6
- Change From Baseline in the Monthly Total Alcohol Consumption (TAC)Time frame: Baseline and Month 6
Locations
39 sites in 4 countries. Site status is shown where the registry gives one.
AT001
Linz, Austria
AT004
Salzburg, Austria
AT003
Vienna, Austria
AT002
Vienna, Austria
FI008
Helsinki, Finland
FI009
Helsinki, Finland
FI007
Jarvenpaa, Finland
FI013
Kuopio, Finland
FI004
Kuusankoski, Finland
FI001
Mikkeli, Finland
FI015
Oulu, Finland
FI003
Tampere, Finland
FI002
Tampere, Finland
FI014
Turku, Finland
FI011
Vantaa, Finland
DE011
Bad Saarow, Germany
DE016
Berlin, Germany
DE005
Berlin, Germany
DE002
Berlin, Germany
DE017
Berlin, Germany
DE008
Berlin, Germany
DE019
Berlin, Germany
DE003
Essen, Germany
DE006
Hamburg, Germany
DE001
Hamburg, Germany
DE007
Leukersdorf, Germany
DE003
Mannheim, Germany
DE014
Munich, Germany
DE010
Regensburg, Germany
DE018
Siegen, Germany
DE020
Wallerfing, Germany
SE011
Gothenburg, Sweden
SE005
Kalmar, Sweden
SE006
Linköping, Sweden
SE001
Malmö, Sweden
SE004
Stockholm, Sweden
SE002
Stockholm, Sweden
SE008
Stockholm, Sweden
SE009
Uppsala, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.